BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 24484248)

  • 1. Use of fluorescence to guide resection or biopsy of primary brain tumors and brain metastases.
    Marbacher S; Klinger E; Schwyzer L; Fischer I; Nevzati E; Diepers M; Roelcke U; Fathi AR; Coluccia D; Fandino J
    Neurosurg Focus; 2014 Feb; 36(2):E10. PubMed ID: 24484248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of 5-aminolevulinic acid-induced fluorescence in 55 different spinal tumors.
    Millesi M; Kiesel B; Woehrer A; Hainfellner JA; Novak K; Martínez-Moreno M; Wolfsberger S; Knosp E; Widhalm G
    Neurosurg Focus; 2014 Feb; 36(2):E11. PubMed ID: 24484249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma.
    Tsugu A; Ishizaka H; Mizokami Y; Osada T; Baba T; Yoshiyama M; Nishiyama J; Matsumae M
    World Neurosurg; 2011; 76(1-2):120-7. PubMed ID: 21839963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
    Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
    J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor detection with 5-aminolevulinic acid fluorescence and Gd-DTPA-enhanced intraoperative MRI at the border of contrast-enhancing lesions: a prospective study based on histopathological assessment.
    Coburger J; Engelke J; Scheuerle A; Thal DR; Hlavac M; Wirtz CR; König R
    Neurosurg Focus; 2014 Feb; 36(2):E3. PubMed ID: 24484256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative confocal microscopy in the visualization of 5-aminolevulinic acid fluorescence in low-grade gliomas.
    Sanai N; Snyder LA; Honea NJ; Coons SW; Eschbacher JM; Smith KA; Spetzler RF
    J Neurosurg; 2011 Oct; 115(4):740-8. PubMed ID: 21761971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence-guided surgery in high grade gliomas using an exoscope system.
    Belloch JP; Rovira V; Llácer JL; Riesgo PA; Cremades A
    Acta Neurochir (Wien); 2014 Apr; 156(4):653-60. PubMed ID: 24468884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of 5-aminolevulinic acid fluorescence-guided surgery on the extent of resection of meningiomas--with special regard to high-grade tumors.
    Cornelius JF; Slotty PJ; Kamp MA; Schneiderhan TM; Steiger HJ; El-Khatib M
    Photodiagnosis Photodyn Ther; 2014 Dec; 11(4):481-90. PubMed ID: 25117928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of 5-aminolevulinic acid in brain tumor surgery: a systematic review.
    Ferraro N; Barbarite E; Albert TR; Berchmans E; Shah AH; Bregy A; Ivan ME; Brown T; Komotar RJ
    Neurosurg Rev; 2016 Oct; 39(4):545-55. PubMed ID: 26815631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of F18-fluoro-ethyl-tyrosin uptake and 5-aminolevulinic acid-induced fluorescence in gliomas.
    Stockhammer F; Misch M; Horn P; Koch A; Fonyuy N; Plotkin M
    Acta Neurochir (Wien); 2009 Nov; 151(11):1377-83. PubMed ID: 19639250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative tissue fluorescence using 5-aminolevolinic acid (5-ALA) is more sensitive than contrast MRI or amino acid positron emission tomography ((18)F-FET PET) in glioblastoma surgery.
    Roessler K; Becherer A; Donat M; Cejna M; Zachenhofer I
    Neurol Res; 2012 Apr; 34(3):314-7. PubMed ID: 22449387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas?
    Hadjipanayis CG; Widhalm G; Stummer W
    Neurosurgery; 2015 Nov; 77(5):663-73. PubMed ID: 26308630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resection of malignant brain tumors in eloquent cortical areas: a new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring.
    Feigl GC; Ritz R; Moraes M; Klein J; Ramina K; Gharabaghi A; Krischek B; Danz S; Bornemann A; Liebsch M; Tatagiba MS
    J Neurosurg; 2010 Aug; 113(2):352-7. PubMed ID: 19911888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of fluorescence-guided resection of recurrent gliomas using five-aminolevulinic acid: retrospective analysis of surgical and neurological outcome in 58 patients.
    Hickmann AK; Nadji-Ohl M; Hopf NJ
    J Neurooncol; 2015 Mar; 122(1):151-60. PubMed ID: 25557106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Finding the anaplastic focus in diffuse gliomas: the value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence.
    Ewelt C; Floeth FW; Felsberg J; Steiger HJ; Sabel M; Langen KJ; Stoffels G; Stummer W
    Clin Neurol Neurosurg; 2011 Sep; 113(7):541-7. PubMed ID: 21507562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative fluorescence-guided resection of high-grade gliomas: a comparison of the present techniques and evolution of future strategies.
    Li Y; Rey-Dios R; Roberts DW; Valdés PA; Cohen-Gadol AA
    World Neurosurg; 2014; 82(1-2):175-85. PubMed ID: 23851210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of neurochemical navigation with 5-aminolevulinic acid during intraoperative MRI-guided resection of intracranial malignant gliomas.
    Yamada S; Muragaki Y; Maruyama T; Komori T; Okada Y
    Clin Neurol Neurosurg; 2015 Mar; 130():134-9. PubMed ID: 25615582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative fluorescence using 5-aminolevulinic acid-induced protoporphyrin IX biomarker as a surgical adjunct in low-grade glioma surgery.
    Valdés PA; Jacobs V; Harris BT; Wilson BC; Leblond F; Paulsen KD; Roberts DW
    J Neurosurg; 2015 Sep; 123(3):771-80. PubMed ID: 26140489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Navigable intraoperative ultrasound and fluorescence-guided resections are complementary in resection control of malignant gliomas: one size does not fit all.
    Moiyadi A; Shetty P
    J Neurol Surg A Cent Eur Neurosurg; 2014 Nov; 75(6):434-41. PubMed ID: 24971685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.
    Roder C; Bisdas S; Ebner FH; Honegger J; Naegele T; Ernemann U; Tatagiba M
    Eur J Surg Oncol; 2014 Mar; 40(3):297-304. PubMed ID: 24411704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.